Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Insulet (PODD) Stock Is Trading Up Today

May 09, 2025 at 14:52 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PODD Cover Image

What Happened?

Shares of insulin delivery company Insulet Corporation (NASDAQ: PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' constant currency revenue, EPS, and EBITDA expectations. Its quarterly revenue guidance also outperformed Wall Street's estimates.

The key number was a 30% jump in constant currency sales, led by strong growth in the U.S. and a big push overseas, where Omnipod sales rose 36%. Zooming out, we think this was a solid print.

Is now the time to buy Insulet? Access our full analysis report here, it’s free.

What The Market Is Telling Us

Insulet’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. But moves this big are rare even for Insulet and indicate this news significantly impacted the market’s perception of the business.

Insulet is up 20% since the beginning of the year, and at $308.26 per share, has set a new 52-week high. Investors who bought $1,000 worth of Insulet’s shares 5 years ago would now be looking at an investment worth $1,372.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article